Nobilis®Reo Live (2177)

Indications

• Clinical term 1
• Common term 1
• Clinical term 2
• Common term 2

Dosage

Children: Refer to the BNF for Children for specific paediatric dosing guidelines.

Adults: Refer to the BNF for specific adult dosing guidelines.

Mechanism of action

Dose acts by modulating the activity of specific neurotransmitter receptors and ion channels, influencing various physiological pathways. Its precise mechanism may involve interactions with G-protein coupled receptors, leading to downstream signaling effects that impact cellular responses.

Pharmacodynamics

Dose exhibits a range of effects depending on the dosage and target tissues. It is known to alter neurotransmitter release, affect ion conductance, and influence metabolic pathways, thereby contributing to its therapeutic efficacy and potential side effects.

Pharmacokinetics

Dose is generally absorbed following administration, with peak plasma concentrations occurring within a specified timeframe. Its distribution is influenced by tissue binding and permeability across cell membranes. The drug is metabolized primarily in the liver, with metabolites being excreted via renal and biliary routes. The half-life can vary based on individual patient factors, including age, liver function, and other concurrent medications.

Indications

• Induction of anesthesia
• Maintenance of anesthesia during surgery
• Sedation for procedures
• Pain management

Dosage

Children: Dosing in pediatric patients must be determined based on the specific agent and the child's age, weight, and clinical condition. Refer to BNF for Children for precise dosing recommendations.

Adults: Dosing varies widely based on the specific anaesthetic agent and the procedure being performed. Refer to specific guidelines or BNF for exact dosing information.

Mechanism of action

Least-acting anaesthetics primarily exert their effects by enhancing inhibitory neurotransmission, particularly through the modulation of gamma-aminobutyric acid (GABA) receptors. This results in increased chloride ion influx into neurons, leading to hyperpolarization and decreased neuronal excitability. Additionally, these agents may inhibit excitatory neurotransmitter pathways, contributing to their anesthetic effects.

Pharmacodynamics

The pharmacodynamics of least-acting anaesthetics involve a balance between sedation and analgesia, with the goal of achieving an appropriate depth of anesthesia for surgical procedures. The effects are dose-dependent, with lower doses providing sedation and higher doses leading to full anesthesia. The therapeutic window is critical, as excessive doses can lead to respiratory depression and cardiovascular instability.

Pharmacokinetics

Least-acting anaesthetics are generally characterized by rapid absorption and distribution, allowing for quick onset of action. They are metabolized primarily in the liver, with some agents undergoing hydrolysis in the plasma. The elimination half-life can vary significantly among different agents, influencing the duration of action. Factors such as age, liver function, and concurrent medications can affect the pharmacokinetics of these agents.

Pregnancy

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Caution is advised; it is recommended to consult a healthcare provider before use.

Storage

Store in a cool, dry place, away from direct light and moisture.

Dosage

Children: Paediatric dosing in micrograms is also highly variable based on the drug and the condition being treated. Refer to the BNF for Children for detailed dosing recommendations.

Adults: Dosage in micrograms varies widely depending on the specific medication and its indication. Consult relevant clinical guidelines or the BNF for precise dosing information.

Mechanism of action

The mechanism of action varies depending on the specific drug being measured in micrograms. For example, many drugs operate by binding to specific receptors or enzymes, leading to a physiological response. This can include agonistic or antagonistic effects on neurotransmitter systems, modulation of immune responses, or alteration of metabolic pathways.

Pharmacodynamics

Pharmacodynamics refers to the effects of the drug on the body, including the relationship between drug concentration and effect. Drugs measured in micrograms often have a steep dose-response curve, meaning small changes in dosage can lead to significant changes in therapeutic and adverse effects. The potency of such drugs is typically high, necessitating careful dosing and monitoring.

Pharmacokinetics

Pharmacokinetics involves the study of how the body absorbs, distributes, metabolizes, and excretes a drug. Drugs administered in microgram doses may exhibit rapid absorption and distribution, especially if given intravenously or sublingually. Metabolism often occurs in the liver, and excretion can be renal or via bile, depending on the drug's chemical properties. Understanding the pharmacokinetics is essential for optimizing therapeutic regimens and minimizing side effects.

Pregnancy

Consult a healthcare professional before use. Safety and efficacy during pregnancy have not been established.

Breast-feeding

Consult a healthcare professional before use. It is not known if this drug is excreted in human milk.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Indications

• Oncolytic virotherapy for cancer treatment
• Research applications in oncology

Dosage

Children: Dosage is determined based on clinical study protocols and should be guided by the prescribing physician.

Adults: Dosage is determined based on the clinical study protocols and should be guided by the prescribing physician.

Mechanism of action

Reovirus exerts its effects primarily through its ability to selectively infect and replicate in cancer cells that have activated Ras signaling pathways. Upon infection, reovirus enters the host cell, where it uses the host's cellular machinery to replicate its RNA genome and produce viral proteins. This replication leads to cell lysis and death, releasing new virions that can infect adjacent tumor cells. Additionally, reovirus activates the host immune system, promoting a broader antitumor immune response.

Pharmacodynamics

Reovirus demonstrates selective cytotoxicity toward tumor cells, particularly those with mutations in RAS genes. The virus triggers apoptotic pathways and engages immune mediators, enhancing the body's ability to recognize and eliminate malignant cells. The immunogenic nature of reovirus also facilitates the activation of dendritic cells and T cells, fostering an adaptive immune response against the tumor.

Pharmacokinetics

The pharmacokinetics of reovirus can vary based on the route of administration and the type of tumor being treated. Upon administration, the virus disseminates throughout the body, but its distribution is often limited by the immune response. The half-life and clearance rate are influenced by the host's immune system and the presence of antibodies against the virus. It is vital to monitor the viral load and immune response to assess therapeutic effectiveness.

Pregnancy

Limited data are available on reovirus use in pregnancy. It is recommended to consider the potential benefits against risks.

Breast-feeding

Data on reovirus excretion in human milk are lacking. Caution is advised when administering to breastfeeding women.

Storage

Reovirus should be stored according to specific manufacturer guidelines, typically at 2-8 degrees Celsius. Avoid freeze-thaw cycles.

Indications

• Bacterial infections
• Viral infections
• Epidemiological studies
• Antibiotic resistance monitoring

Dosage

Children: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Adults: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Mechanism of action

The mechanism of action for a strain depends on the type of microorganism it represents. For pathogenic bacteria, the strain may produce toxins, evade the host's immune response, or possess resistance mechanisms that allow it to survive in the presence of antibiotics. For viruses, strains may exhibit mutations that alter their ability to infect host cells or evade antiviral therapies.

Pharmacodynamics

Pharmacodynamics in the context of strains involves the interaction between the strain and the host's immune system, as well as the effects of specific antimicrobial agents on the strain. These interactions can influence the efficacy of treatments and the development of resistance.

Pharmacokinetics

Pharmacokinetics is not directly applicable to strains themselves but rather to the drugs used to treat infections caused by specific strains. Factors such as absorption, distribution, metabolism, and excretion of antimicrobial agents can vary depending on the strain's characteristics and the site of infection.

Pregnancy

There is limited information on the safety of strain in pregnancy. It is advisable to consult healthcare professionals for guidance.

Breast-feeding

Safety during breastfeeding is not well established. It is recommended to seek medical advice before use.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.